ストックスクリーナーアプリを入手
81.66
4.01%
3.15
アフターアワーズ：
80.10
-1.56
-1.91%
前日終値:
$78.51
開ける：
$77.99
24時間の取引高:
480.98K
Relative Volume:
1.69
時価総額：
$1.18B
収益：
$1.80M
当期純損益:
$1.76B
株価収益率:
0.6881
EPS:
118.674
ネットキャッシュフロー:
$-149.23M
1週間 パフォーマンス:
+42.54%
1か月 パフォーマンス:
+142.46%
6か月 パフォーマンス:
+562.29%
1年 パフォーマンス:
+409.42%
1日の値動き範囲:
$75.13
$83.95
1週間の範囲:
$53.39
$83.95
52週間の値動き範囲:
$10.80
$83.95
Inhibrx Biosciences Inc Stock (INBX) Company Profile
名前
Inhibrx Biosciences Inc
セクター
電話
(858) 795-4220
住所
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
INBX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
81.66 | 1.14B | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Inhibrx Biosciences Inc Stock (INBX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-23 | 開始されました | JMP Securities | Mkt Perform |
| 2024-01-23 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-03-16 | 開始されました | SMBC Nikko | Outperform |
| 2021-09-21 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-09-14 | 開始されました | Credit Suisse | Outperform |
| 2020-09-14 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Inhibrx Biosciences Inc (INBX) 最新ニュース
Inhibrx Biosciences stock hits all-time high of 83.93 USD By Investing.com - Investing.com Australia
Inhibrx Biosciences stock hits all-time high of 83.93 USD - Investing.com
Is Inhibrx Biosciences Inc. stock resilient to inflationJuly 2025 Snapshot & AI Forecasted Stock Moves - newser.com
Tick level data insight on Inhibrx Biosciences Inc. volatilityJuly 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com
What does recent volatility data suggest for Inhibrx Biosciences Inc.Quarterly Risk Review & AI Optimized Trading Strategy Guides - newser.com
Inhibrx Biosciences Inc. stock daily chart insightsPortfolio Risk Report & Risk Adjusted Buy/Sell Alerts - newser.com
Will Inhibrx Biosciences Inc. stock benefit from sector rotationLayoff News & Real-Time Volume Analysis Alerts - newser.com
Biotech Stocks Hit 52-Week Highs: MTSR, INSM, ABVX, MAZE Lead October 30 Surge - RTTNews
What Wall Street predicts for Inhibrx Biosciences Inc. stock priceJuly 2025 Breakouts & Free Community Consensus Stock Picks - newser.com
Why Inhibrx Biosciences Inc. stock appeals to analystsWatch List & Daily Chart Pattern Signals - newser.com
How to recover losses in Inhibrx Biosciences Inc. stock2025 Short Interest & Community Verified Trade Signals - newser.com
Inhibrx Biosciences (NASDAQ:INBX) Trading Up 7.8%What's Next? - MarketBeat
Published on: 2025-10-30 05:00:27 - newser.com
Published on: 2025-10-30 02:27:04 - newser.com
Inhibrx Biosciences (NASDAQ:INBX) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Regression analysis insights on Inhibrx Biosciences Inc. performanceTrade Exit Report & Community Consensus Picks - newser.com
Inhibrx Biosciences (NASDAQ:INBX) Hits New 12-Month HighHere's What Happened - MarketBeat
How hedge fund analytics apply to Inhibrx Biosciences Inc. stockTrade Volume Summary & Low Drawdown Momentum Ideas - newser.com
Published on: 2025-10-28 03:10:26 - newser.com
Published on: 2025-10-28 00:45:26 - newser.com
How Inhibrx Biosciences Inc. stock valuations compare to rivalsMarket Movement Recap & Daily Entry Point Trade Alerts - Fundação Cultural do Pará
Is Inhibrx Biosciences Inc. stock supported by innovation pipelineJuly 2025 Selloffs & Entry Point Confirmation Signals - Fundação Cultural do Pará
Is Inhibrx Biosciences Inc. stock recession proof2025 Trade Ideas & Free Community Consensus Stock Picks - Fundação Cultural do Pará
Inhibrx Biosciences: Cruising Toward FDA Approval, But Getting Ahead Of Itself - Seeking Alpha
Multi factor analysis applied to Inhibrx Biosciences Inc.Price Action & Real-Time Volume Trigger Notifications - newser.com
What high frequency data says about Inhibrx Biosciences Inc.Earnings Overview Summary & Low Volatility Stock Suggestions - newser.com
Inhibrx Preps US Filing For Ozekibart In Rare Bone Cancer After Phase II Win - Citeline News & Insights
US Stocks Jump To Records Amid Weak Inflation: Investor Fear Eases, Greed Index Remains In 'Fear' Zone - Benzinga
Inhibrx Biosciences Inc (INBX) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):